Wealth Enhancement Trust Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wealth Enhancement Trust Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2K	Buy	+59	New	+$12.9K	﹤0.01%	673

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wealth Enhancement Trust Services's JAZZ Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 59 shares worth $14.2K. The stake represents ﹤0.01% of the portfolio and ranks #673 among its holdings.

488 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Wealth Enhancement Trust Services held 59 shares of Jazz Pharmaceuticals worth $14.2K as of Q2 2026.
Jazz Pharmaceuticals was a new Wealth Enhancement Trust Services position in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #673 holding.
488 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.